Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 1.2.2021 | EN | Official Journal of the European Union | C 35/55 |

---

Action brought on 30 November 2020 — MiMedx Group v EUIPO — DIZG (Epiflex)

(Case T-706/20)

(2021/C 35/73)

Language of the case: English

Parties

Applicant: MiMedx Group, Inc. (Marietta, Georgia, United States) (represented by: J. Bogatz and Y. Stone, lawyers)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: DIZG Deutsches Institut für Zell- und Gewebeersatz gGmbH (Berlin, Germany)

Details of the proceedings before EUIPO

Proprietor of the trade mark at issue: Other party to the proceedings before the Board of Appeal

Trade mark at issue: European Union word mark Epiflex — European Union trade mark No 1 281 385

Procedure before EUIPO: Cancellation proceedings

Contested decision: Decision of the Second Board of Appeal of EUIPO of 25 September 2020 in Case R 133/2020-2

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | annul the contested decision |

|  |  |
| --- | --- |
| — | order EUIPO and the other Party to the proceedings to pay the costs incurred by the applicant. |

Pleas in law

|  |  |
| --- | --- |
| — | Infringement of Article 58 of Regulation (EU) 2017/1001 of the European Parliament and of the Council in conjunction with Article 19(1) of Commission Delegated Regulation (EU) 2017/1430; |

|  |  |
| --- | --- |
| — | Infringement of the principle of equality as laid down in Article 20 in conjunction with Article 41 of the Charter of Fundamental Rights of the European Union (‘the Charter’); |

|  |  |
| --- | --- |
| — | Infringement of the right to good administration as laid down in Article 41(1) of the Charter; |

|  |  |
| --- | --- |
| — | Infringement of right to a fair trial as laid down in Article 47 of the Charter; |

|  |  |
| --- | --- |
| — | Infringement of Article 95(2) of Regulation (EU) 2017/1001 of the European Parliament and of the Council in conjunction with Articles 19(1), third sentence, and 10(7) of Commission Delegated Regulation (EU) 2017/1430. |

---

[Top](#document1)